Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) just unveiled an update.
Shanghai Pharmaceuticals Holding Co., Ltd. has announced a board meeting scheduled for October 30, 2025, to approve the company’s third-quarter results and consider interim dividend payments. This meeting is significant as it will provide insights into the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.
The most recent analyst rating on (HK:2607) stock is a Buy with a HK$13.50 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a major player in the pharmaceutical industry in China, focusing on the production and distribution of pharmaceutical products and services.
Average Trading Volume: 3,634,188
Technical Sentiment Signal: Buy
Current Market Cap: HK$77.4B
For detailed information about 2607 stock, go to TipRanks’ Stock Analysis page.